Skip to main content
. 2022 Aug 9;16(8):12262–12275. doi: 10.1021/acsnano.2c03075

Table 2. Pharmacokinetics of MSAs with Different DOFs.

  T1/2α (h)
T1/2β (h)
  avg SD avg SD
AD-Alb(6) 6.75 0.85 19.08 0.92
AD-Alb(11) 6.98 1.80 21.05 5.21
Man(2)-Alb 5.19 0.95 24.84 6.73
Man(4)-Alb 3.44 0.14 20.24 1.11
Man(6)-Alb 3.49 0.17 19.21 4.05
Man(8)-Alb 2.99 0.12 16.48 1.65